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Summary Bcl-2 is an oncoprotein that is widely known to promote cell survival by inhibiting
apoptosis. We explored the consequences of different expression paradigms on the cellular
action of Bcl-2. Using either transient or stable transfection combined with doxycycline-
inducible expression, we titrated the cellular concentration of Bcl-2. With each expression
paradigm Bcl-2 was correctly targeted to the endoplasmic reticulum and mitochondria. How-
ever, with protocols that generated the greatest cellular concentrations of Bcl-2 the structure
of these organelles was dramatically altered. The endoplasmic reticulum appeared to be sub-
stantially fragmented, whilst mitochondria coalesced into dense perinuclear structures. Under
these conditions of high Bcl-2 expression, cells were not protected from pro-apoptotic stimuli.
Rather Bcl-2 itself caused a significant amount of spontaneous cell death, and sensitised the
cells to apoptotic agents such as staurosporine or ceramide. We observed a direct correlation
between Bcl-2 concentration and spontaneous apoptosis. Expression of calbindin, a calcium
buffering protein, or an enzyme that inhibited inositol 1,4,5-trisphosphate-mediated calcium
release, significantly reduced cell death caused by Bcl-2 expression. We further observed that
high levels of Bcl-2 expression caused lipid peroxidation and that the deleterious effects of
Bcl-2 could be abrogated by the reactive oxygen species (ROS) scavenger Trolox. When stably
expressed at low levels, Bcl-2 did not corrupt organelle structure or trigger spontaneous apop-
tosis. Rather, it protected cells from pro-apoptotic stimuli. These data reveal that high cellular
concentrations of Bcl-2 lead to a
the appropriate expression para
of Bcl-2.
© 2007 Elsevier Ltd. All rights re
∗ Corresponding author. Tel.: +44 1223 496443; fax: +44 1223 496033.
E-mail address: martin.bootman@bbsrc.ac.uk (M.D. Bootman).
0143-4160/$ — see front matter © 2007 Elsevier Ltd. All rights reserved.
doi:10.1016/j.ceca.2007.11.014calcium- and ROS-dependent induction of death. Selection of
digm is therefore crucial when investigating the biological role
served.
21
B
i
h
m
o
i
s
p
c
t
t
c
c
t
G
t
l
R
c
i
p
o
t
s
t
o
t
B
o
i
r
q
S
c
(
[
l
[
c
a
a
e
c
t
e
b
n
c
s
s
s
E
s
o
t
t
e
t
c
c
W
g
s
e
s
a
o
e
i
e
i
s
f
s
f
s
i
t
t
t
a
a
a
2
2
H
f
p
b
c
t
E
a
p
r
g
S
g
A
2
p
v
B
i
2
t
244
. Introduction
cl-2 is a well-known anti-apoptotic protein [1]. The
dentity and function of Bcl-2 were determined from a
uman B-cell lymphoma that had undergone a chromoso-
al translocation, which placed the Bcl-2 gene downstream
f the IgH heavy chain enhancer [2]. The resultant
ncrease in Bcl-2 expression gave the cells a profound
urvival advantage [3]. Bcl-2 is a 26 kDa protein that
ost-translationally inserts into cellular membranes via its
-terminal tail, with the amino-terminal bulk of the pro-
ein facing the cytosol. It has been shown to be present on
he endoplasmic reticulum (ER), nuclear envelope and mito-
hondria [4]; the major sites of calcium (Ca2+) flux within
ells.
Ca2+ controls numerous cellular activities [5]. In par-
icular, it is established that Ca2+ can promote apoptosis.
ross Ca2+ signals have been monitored in cells exposed
o various pro-apoptotic stimuli [6,7], and buffering cel-
ular Ca2+ can delay, or sometimes inhibit, cell death [7].
ecent studies have identified a number of ways in which
ells’ Ca2+ signalling systems can be modulated to either
nhibit or promote apoptosis. It appears that many of the
rocesses involved in storage, homeostasis or liberation
f Ca2+ are targets of various components of the apop-
otic machinery [8]. Of particular relevance to the present
tudy, the release of Ca2+ from intracellular stores appears
o be a key regulatory step [9]. Indeed, Bcl-2, and some
f its homologues, have been demonstrated to modulate
he mobilisation of the ER Ca2+ pool [10—13]. Somehow
cl-2 prevents Ca2+ increases, or reduces the magnitude
f Ca2+ transients so that cells can tolerate toxic death-
nducing insults and survive until Ca2+ homeostasis has been
e-established [7].
There have been many studies examining the conse-
uence of Bcl-2 expression on ER Ca2+ homeostasis [8].
everal of these investigations have observed significant
hanges in ER Ca2+ content, but the direction of the effect
i.e. increase or decrease) has been curiously inconsistent
14]. Other studies have proposed that Bcl-2 regulates cel-
ular Ca2+ signals via interaction with Ca2+ release channels
10,15], Ca2+ pumps [16], Ca2+ leak pathways [17] or mito-
hondria [18]. As pointed out recently [8], thesemechanisms
re not necessarily mutually exclusive. However, whether
ll of these mechanisms are all physiologically valid and
qually significant is presently controversial. Some of these
ontroversies may however be due to the cellular con-
ext; for example the cell type and the InsP3R isoforms
xpressed. Clearly, more work is required to establish the
ona fide interaction between Bcl-2 and cellular Ca2+ sig-
alling machinery.
The bulk of studies examining the impact of Bcl-2 on
ellular Ca2+ signalling have employed heterologous expres-
ion of the gene encoding Bcl-2 under the control of a
trong constitutively-active promoter. Both transient and
tably transfected Bcl-2-expressing cells have been used.
ach of these approaches has merits and drawbacks. Tran-
ient transfection is probably the most common method of
ver-expressing proteins. Gene expression is short-term as
he heterologously introduced DNA is not integrated into
he host genome. This approach allows for rapid over-
xpression of proteins of interest, without adaptation of
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he cell. However, very high average levels of expression
an occur (>5—10-fold), albeit with considerable cell-to-
ell variability, and transfection efficiency is unpredictable.
ith stable over-expression, the gene of interest is inte-
rated into the host genome, thereby offering long-term
electable expression across an entire cell population. How-
ver, this experimental model takes time to set up, the
ite of integration into the genome cannot be controlled
nd adaptation can occur in cells in response to the stably
ver-expressed protein.
In our attempts to develop an experimental model to
xamine the role of Bcl-2 on Ca2+ signalling, we have exam-
ned the cellular consequences of transient and stable Bcl-2
xpression. Our aim was to produce a model with the follow-
ng characteristics: the sub-cellular localisation should be
imilar to that of native Bcl-2, over-expressed Bcl-2 should
unction in an anti-apoptotic manner, levels of expression
hould not be too high (<5-fold higher than endogenous), and
urthermore, endogenous levels of Bcl-2 in the cell line used
hould be low so that the effects of expression of Bcl-2 and
ts mutants can be directly monitored. During the course of
his work, we observed that the experimental paradigm used
o modulate Bcl-2 expression had dramatic consequences for
he cells. Rather than being pro-survival, when expressed
t a high level, it was deleterious to the cell, inducing
poptosis as well as sensitising the cells to pro-apoptotic
gents.
. Materials and methods
.1. Cell lines and reagents
uman Embryonic Kidney 293 cells (HEK-293) were obtained
rom Microbix (Ontario, Canada). The cells were obtained at
assage 31, and used for no more than 15 further passages
efore being revived. Tetracyline-Regulated Expression 293
ells (T-REx-293), which are HEK-293 cells stably expressing
he tetracycline repressor, were obtained from Invitrogen.
xpression of the tetracycline repressor in TREx-293 cells
llows for repression and de-repression of a modified CMV
romoter containing Tet operator sequences. This enables
egulation of genes contained within a pcDNA4/TO (Invitro-
en) expression vector [19]. Ceramide was obtained from
igma, staurosporine from Calbiochem, fura2 from Invitro-
en and anti-malondialdehye (MDA) antibodies were from
bCam.
.2. Expression plasmids
EGFP-C1 was obtained from Clontech. The expression
ector for GFP-tagged wild type human Bcl-2 (pGFP-
cl-2) has been previously described [4]. To create the
nducible GFP-Bcl-2 expression vector (pcDNA4/TO-GFP-Bcl-
) (TO-GFP-Bcl-2) the BglII/EcoR1 DNA fragment containing
he cDNA encoding Bcl-2 was excised from pGFP-Bcl-
and subcloned by ligation into BamH1/EcoR1-digestedcDNA4/TO-GFP. pcDNA4/TO-GFP was created by subcloning
he Eco47III/Dra1 DNA fragment containing the cDNA encod-
ng GFP and the multiple cloning sequence from pEGFP-C1
nto similarly digested pcDNA4/TO. mRFP-calbindin was gen-
rated by subcloning a cDNA fragment encoding rat calbindin
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(kind gift of B. Schwaller) at the 3′ end of mRFP (kind
gift of R. Tsien). Specifically, mRFP was amplified by PCR
using primers to append Nhe1 and HindIII restriction sites
to its 5′ end 3′ end, respectively. Subsequent to diges-
tion, this PCR product was ligated into a similarly digested
pEGFP-C1 (Clontech), creating pmRFP-C1. To insert cal-
bindin into this vector, it was first PCR-amplified using
primers to append a HindIII restriction site to its 5′ end and
a BamHI restriction site to its 3′ end. Following restriction
digest this construct was ligated into a similarly digested
pmRFP-C1.
2.3. Transient transfection
Cells were transfected at ∼75% confluency, 16 h prior
to experimentation, using GeneJuice transfection reagent
(Novagen), JetPEI transfection reagent (Q-BIOgene) or Lipo-
fectamine 2000 (Invitrogen) according to themanufacturers’
protocols. For imaging and flow cytometry, cells were trans-
fected using GeneJuice or JetPEI, but for experiments where
greater than 90% transfection was required, Lipofectamine
2000 was used.
2.4. Stable transfection
HEK-293 cells stably expressing GFP or GFP-Bcl-2 were gen-
erated by initial transient transfection, as above, followed
by selection for expressing cells and maintenance in media
containing 700g/ml G418. To ensure that the whole pop-
ulation was expressing the constructs following selection,
cells were sorted based on their GFP fluorescence using
a FACSDiVA cell sorter. Note that individual clones were
not isolated. Rather the entire transfected population was
selected and maintained.
2.5. Confocal imaging
To visualise the endoplasmic reticulum, cells were loaded
with 500 nM ER-Tracker Blue-White DPX (Invitrogen) for
20min in HBSS at 37 ◦C, then washed twice in HBSS and
mounted in an imaging chamber. The imaging chamber was
then placed in a heated stage-plate, which was maintained
at 37 ◦C. To visualise mitochondria, cells were loaded whilst
on the microscope stage with 250 nM tetramethylrhodamine
ethyl ester (TMRE), a potentiometric mitochondrial dye
(Invitrogen). Images of live cells were captured using a Zeiss
LSM 510 META point-scanning confocal microscope, with a C-
apochromat 63×, 1.2 numerical aperture water objective,
and a pinhole set to 1 Airy unit for the red channel and
corresponding pinholes set to give the same optical slice
depth (0.7m) for all other channels. Using transmitted
light, a differential interference contrast (DIC) image was
taken simultaneously. GFP was excited at 488 nm using a
multi-line argon laser, and the emission was collected using
a 505—550 nm band pass filter. ER-tracker Blue-White DPX
was excited at 405 nm using a blue diode laser and emission
was collected using a 420—480 nm band pass filter. TMRE was
excited at 561 nm using a red HeNe laser and emission was
collected using the Zeiss Meta spectral detector between
603 and 688 nm.
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.6. Flow cytometry
n order to determine the level of GFP fluorescence, cells
ere analysed using a Becton Dickinson FACSCalibur. GFP
as excited at 488 nm and emission was collected using
530/30 nm band pass filter. To determine the proportion
f cells with sub-G1 DNA content, cells were trypsinised
o detach them from their plastic culture flasks, and then
esuspended in the original media in which they were grown
to retain any apoptotic cells that were already detached).
he cells were then washed twice in PBS and fixed in 70%
thanol/30% PBS at 4 ◦C overnight. Fixed cells were washed
wice in PBS and resuspended at 10× 106 cells/ml. They
ere then passed through a 25-gauge needle and treated
ith 25g/ml RNAse for 10min. The cells were then stained
ith 0.5mg/ml PI in the presence of 0.6% IGEPAL-630 for 2 h
n ice. Cells were analysed for GFP and PI fluorescence using
Becton Dickinson FACSCalibur using excitation at 488 nm.
FP fluorescence emission was collected using a 530/30 nm
and pass filter, and PI fluorescence using a 670 nm long pass
lter.
.7. Immunoblotting
mmunoblotting was used to detect expression levels of
cl-2, InsP3R isoforms and cleavage of caspase-3. Lysates
ere prepared as previously described [20], though as many
f the cells used in these experiments were apoptotic,
oth cells in the growth media and those that remained
ttached were pooled. To this end, cells were scraped
nto the overlying media prior to washing. 20g of protein
ysates were resolved on 1mm thick self-poured polyacry-
amide gels. GFP-Bcl-2 and caspase-3 were resolved on 14
nd 16% gels, respectively and transferred to nitrocellulose.
FP-Bcl-2 was detected using a monoclonal anti-Bcl-2 anti-
ody (dilution 1:200, Santa Cruz) and caspase-3 was probed
or using a polyclonal anti-caspase-3 antibody (dilution
:250, Cell Signalling Technology). Enhanced chemilumines-
ence (ECL, Pierce) (for Bcl-2) or ECL Plus (Amersham)
for caspase-3) were used to detect immunoreactive bands
fter incubation with secondary antibodies conjugated to
orseradish peroxidase (HRP) (dilution 1:10000, Jackson
mmunoResearch,). To determine band intensity, films were
igitised using a Microtek ScanMaker i900 scanner, then
mages were black-white inverted and signals correspond-
ng to immunoreactive bands were quantitated using ImageJ
oftware (http://rsb.info.nih.gov/ij/).
.8. Fura-2 imaging of transfected cells
ideoimaging of Fura-2-loaded cells was performed as pre-
iously described using a Sutter (Lambda Technologies,
rattleboro) filter wheel-based imaging system [21].
.9. ImmunofluorescenceDA was detected by immunofluorescent staining of cells
hat had either been transfected with Bcl-2 (16 h post-
ransfection) or that had been exposed to ionomycin (10M;
h). To this end, cells were fixed and processed for
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mmunofluorescence as described previously [20]. MDA was
etected using a rabbit polyclonal antibody diluted 1:50
n PBS containing 0.1% TRITON X-100 and 5% goat serum.
ntibody staining was visualised using an anti-rabbit ALEXA-
68 conjugated secondary antibody (dilution 1:500). Images
ere captured using a Zeiss LSM 510 META confocal micro-
cope using a plan apochromat 60×, 1.40 n.a. oil immersion
bjective.
. Results
.1. Localisation and expression of transiently
ver-expressed GFP-Bcl-2o examine the localisation of heterologously expressed
cl-2, we employed a GFP-tagged form of wild-type Bcl-2
GFP-Bcl-2) [4]. GFP was appended to the NH2-terminus of
cl-2, so as not to disrupt its COOH-terminal membrane tar-
n
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igure 1 Localisation and expression of transiently transfected GFP
maged or harvested 16 h post-transfection. (A) Representative confo
FP-Bcl-2 fluorescence. (Aii) Cells were loaded with ER-Tracker Blue-
itochondrial structure. (Aiv) Transmitted light DIC image. (Av) G
verlay. Scale bar = 10m. (Bi) over-expression of GFP-Bcl-2 was co
nd anti-GFP antibodies (see arrows). -actin was used as a loadi
he presence of endogenous Bcl-2 (see arrow). Blots are represen
mages of cells transiently transfected with GFP-Bcl-2 showing disrup
ere loaded with ER-Tracker Blue-White DPX to illustrate ER struct
ransmitted light DIC image. (Cv) GFP/ER-Tracker/TMRE co-localis
verlay. Scale bar = 10m. (D) Using confocal microscopy, fields of
ata represents the mean± S.E.M. of at least 30 fields of cells per co
ays. Statistical significance is denoted by (***p < 0.001).C.J. Hanson et al.
eting sequence. Confocal imaging of live HEK-293 cells 16 h
ost-transfection revealed that GFP-Bcl-2 co-localised with
oth the ER and mitochondria, thereby demonstrating the
orrect sub-cellular targeting of the fusion protein (Fig. 1A).
ver-expression of GFP-Bcl-2 was confirmed by immunoblot-
ing of total cell lysates, with both anti-Bcl-2 and anti-GFP
ntibodies (Fig. 1B). Transiently over-expressed GFP-Bcl-2
igrated at the expected molecular mass, and the tran-
ient transfection protocol resulted in substantially higher
evels of Bcl-2 compared to endogenous Bcl-2 in HEK-293
ells (which required a longer exposure for visualisation,
ndicating low expression levels; Fig. 1Bii). A lower molecu-
ar weight band was also detected using the Bcl-2 antibody,
hich migrated at approximately the same mass as endoge-
eous Bcl-2. Since this was not detected in GFP-transfected
ells, it is likely that it was due to proteolysis of the GFP-Bcl-
fusion protein. Using FACS analysis to detect GFP positive
ells, it was evident that ∼40% of the transiently transfected
ell population expressed GFP-Bcl-2, and that the levels of
-Bcl-2, and its effect on organelle structure. HEK-293 cells were
cal images of cells transiently transfected with GFP-Bcl-2. (Ai)
White DPX to illustrate ER structure and (Aiii) TMRE to highlight
FP/ER-Tracker/TMRE overlay. (Avi) GFP/ER-Tracker/TMRE/DIC
nfirmed by immunoblotting of total cell lysates with anti-Bcl-2
ng control. (Bii) A longer exposure of control cells confirmed
tative of at least 3 experiments. (C) Representative confocal
ted organelle structure. (Ci) GFP-Bcl-2 fluorescence. (Cii) Cells
ure and (Ciii) TMRE to highlight mitochondrial structure. (Civ)
ation overlay. (Cvi) GFP/ER-Tracker/TMRE/DIC co-localisation
view were scored for cells with abnormal organelle structure.
verslip, from 3 independent coverslips per day, on 3 individual
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GFP fluorescence, which correspond with Bcl-2 expression
levels, varied greatly (Fig. 4D).3.2. Transiently over-expressed Bcl-2 disrupts
organelle structure
During examination of the cells transiently transfected with
the GFP-Bcl-2 expression vector, it became obvious that
t
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o
Figure 2 Transient transfection of GFP-Bcl-2 induces apoptosis and
with staurosporine (4M; 4 h) or ceramide (30M; 16 h) as indicate
proportion of cells with sub-G1 DNA content was determined by FA
histograms of (Ai) GFP-transfected cells and (Aii) GFP-Bcl-2-transfec
of at least 3 individual experiments. Statistical significance is deno
was examined by immunoblotting of total cell lysates with an anti
exposures shown, arrows indicate cleaved caspase-3. -actin was use
3 experiments.optotic effect 247
large proportion (93± 3%) of the cells contained aggre-
ates of GFP-Bcl-2, and had disrupted organelle morphology.
verlays of GFP-Bcl-2 fluorescence and specific organelle
arkers showed that both the ER and mitochondrial struc-
ures were affected. This is evident in Fig. 1C, which shows
hat all the cells expressing GFP-Bcl-2 (the green cells in
anel Ci) had both compromised ER (panel Cii) and mito-
hondria (panel Ciii). Expression of GFP alone did not affect
rganelle morphology (Fig. 1D). Additional experiments,
sensitises cells to apoptotic stimuli. HEK-293 cells were treated
d. Cells were harvested 16 h post-transfection. (A and B) The
CS analysis of PI-stained cells. (A) Representative frequency
ted cells. (B) Sub-G1 data is represented as the mean± S.E.M.
ted by (**p < 0.01) and (***p < 0.001). (C) Caspase-3 activation
-caspase-3 antibody, with both short (top) and long (bottom)
d as a loading control. The blots are representative of at least
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arried out in HeLa cells, and caspase-9 dominant-negative
ung epithelial (IMR-90) cells, showed that transiently over-
xpressed GFP-Bcl-2 disrupted organelle structure in a
imilar proportion of cells, indicating that the effect of Bcl-
was not cell type specific (data not shown). To rule out
dverse effects of specific transfection reagents, GeneJuice
Novagen; cellular protein and novel polyamine), JetPEI
Qbiogene; linear polyethylenemine) and Lipofectamine
000 (Invitrogen; cationic lipid formulation) were all used
o transiently transfect GFP-Bcl-2. Similar results were seen
ndependent of the transfection reagent employed (data not
hown). In order to determine whether the GFP tag at the
H2-terminus was contributing to the damaging effects of
ransiently over-expressed GFP-Bcl-2, an untagged version
f Bcl-2 and a Bcl-2 construct with monomeric red fluo-
escent protein appended to the NH2-terminus (RFP-Bcl-2)
ere employed. Similarly to GFP-Bcl-2, untagged Bcl-2 and
FP-Bcl-2 caused disruption of organelle structure (data not
hown).
.3. Transiently over-expressed Bcl-2 functions in
pro-apoptotic manner
n addition to changes in organelle morphology, HEK-293
ells transiently transfected with Bcl-2 were observed to
ecome rounded-up and detach from the coverslips, in con-
rast to the characteristically flat adherent control cells.
urthermore, the Bcl-2-transfected cells displayed morpho-
ogical features of apoptosis, including cell shrinkage and
lebbing. To quantitate the putative induction of apoptosis
ore precisely, flow cytometry was used to measure DNA
ragmentation, which is manifest as an increase in the num-
er of cells having a DNA content below that observed in
ells in the G1 phase of the cell cycle (i.e. sub-G1). For
his purpose, DNA was stained in fixed cells with propidium
odide (PI). Our results clearly indicated that a significant
roportion of cells transiently over-expressing GFP-Bcl-2,
elected by FACS, were apoptotic. This is evident in Fig. 2A,
hich illustrates the difference in DNA content between
EK-293 cells transfected with either GFP alone (panel Ai)
r GFP-Bcl-2 (panel Aii). The large sub-G1 peak in the GFP-
cl-2-expressing cells indicates a significant induction of
poptosis. Moreover, in addition to causing cell death, tran-
ient transfection of GFP-Bcl-2 sensitised the cells to the
ro-apoptotic stimuli ceramide and staurosporine. Applica-
ion of staurosporine (4M; 4 h) or ceramide (30M; 16 h) to
he GFP-Bcl-2-transfected cells increased the proportion of
ub-G1 cells, from 27± 3% in controls, to 58± 4 and 44± 2%,
espectively (Fig. 2B). These data indicate that not only was
FP-Bcl-2 pro-apoptotic when transiently over-expressed
ut it also sensitised cells to the effects of apoptotic induc-
rs.
Though PI staining is a widely used assay for detect-
ng apoptotic cells, cellular DNA can be decreased through
ther processes than apoptosis, such as necrosis [22]. To
urther corroborate the sub-G1 data, we examined the
ntegrity of caspase-3, which is cleaved and activated by
pstream caspases (e.g. caspase-8 and caspase-9). Cas-
ase 3 is an ‘executioner’ protease that is responsible for
any of the caspase-dependent events, such as EndoG
leavage, required for apoptosis to progress. Total cell
e
F
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sC.J. Hanson et al.
ysates from cells transiently over-expressing GFP-Bcl-2,
ere resolved by SDS-PAGE and immunoblotted using an
nti-caspase-3 antibody, which detects both the inactive
∼32 kDa) and the active proteolytically processed protein
one or more fragments between 14 and 21 kDa). In agree-
ent with the sub-G1 DNA content data, cleaved caspase-3
as detected in cells transiently over-expressing GFP-Bcl-
(Fig. 2C). Treatment with staurosporine or ceramide
ncreased the appearance of active caspase-3 in the GFP-
cl-2-transfected cells. The cell death induced by transient
ver-expression of GFP-Bcl-2 was prevented using the
ompetitive irreversible cell-permeant caspase inhibitor
VAD-FMK. FACS analysis of sub-G1 DNA in PI-stained
ells 16 h post-transfection with GFP-Bcl-2 revealed that
VAD-FMK (10M; 16 h) reduced the proportion of cells
ndergoing apoptosis from 27± 3% to 4± 0.6% (n = 3). Fur-
hermore, zVAD-FMK prevented the cleavage of caspase-3
ollowing transient transfection of Bcl-2 (data not shown).
hese data confirmed that transient transfection of Bcl-
induced apoptotic cell death in a caspase-dependent
anner.
.4. Localisation and expression of stably
ver-expressed GFP-Bcl-2
ince, in our hands, transient transfection of Bcl-2 caused
ell death and sensitised cells to pro-apoptotic stimuli, we
xplored the effects of stably expressing Bcl-2 (see Section
for generation of stable cells). Live-cell confocal imaging
as used to assess the sub-cellular distribution of GFP-Bcl-
in the stable clones. GFP-Bcl-2 co-localised with the ER
arker, ER-Tracker Blue-White DPX, and the mitochondrial
arker, TMRE, indicating correct sub-cellular localisation
Fig. 3A). Over-expression was confirmed by resolving total
ell lysates, using SDS-PAGE, and immunoblotting with
nti-GFP and anti-Bcl-2 antibodies (Fig. 3B). Flow cytom-
try revealed that 100% of cells were positive for green
uorescence, and thus expressing GFP-Bcl-2. Observation
f cells stably over-expressing GFP-Bcl-2, using confocal
icroscopy, showed that significantly fewer cells had dis-
upted organelle structure and that the disruption appeared
o be less severe. Only 33± 3% of cells exhibited organelle
isruption, which was almost three-fold lower than that
bserved when GFP-Bcl-2 was transiently over-expressed
Fig. 3C). Furthermore, the DIC images revealed that the
ells were not rounding-up or blebbing, and therefore not
ying.
.5. Stably over-expressed Bcl-2 functions in an
nti-apoptotic manner
o determine whether stably over-expressed GFP-Bcl-2
ould function in an anti-apoptotic manner, levels of sub-G1
NA and caspase-3 cleavage were examined. Stable expres-
ion of GFP-Bcl-2 did not induce apoptosis, as the proportion
f cells displaying sub-G1 DNA content was <3%, which was
quivalent to that observed in control GFP expressing cells.
urthermore GFP-Bcl-2 expressing cells were protected from
taurosporine-induced apoptosis, indicating that Bcl-2 was
unctioning correctly (Fig. 3D). Unlike transient expres-
ion of GFP-Bcl-2, stable introduction of the protein did
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Figure 3 Localisation of stably transfected GFP-Bcl-2, which functions in an anti-apoptotic manner. HEK-293 cells stably expressing
GFP-Bcl-2 were either imaged or harvested for immunoblotting. (A) Representative confocal images of cells stably over-expressing
GFP-Bcl-2. (Ai) GFP-Bcl-2 fluorescence. (Aii) Cells were loaded with ER-Tracker Blue-White DPX to illustrate ER structure and (Aiii)
TMRE to highlight mitochondrial structure. (Aiv). Transmitted light DIC image. (Av) GFP/ER-Tracker/TMRE overlay. (Avi) GFP/ER-
Tracker/TMRE/DIC overlay. Scale bar = 10m. (B) over-expression of GFP-Bcl-2 was confirmed by immunoblotting total cell lysates
with anti-Bcl-2 (see arrow). -actin was used as a loading control. Blots are representative of at least 3 experiments. (C) Using
confocal microscopy, fields of view were scored for cells with disrupted organelle structure. Data represents the mean± S.E.M. of
at least 30 fields per coverslip, from 3 independent coverslips per day, on 3 individual days. The corresponding data obtained from
cells transiently transfected with the GFP-Bcl-2 expression vector is presented for comparison. (D) The proportion of cells with
sub-G1 DNA content was determined by FACS analysis of PI-stained cells. Sub-G1 data is represented as the mean± S.E.M. of at
least 3 individual experiments. The corresponding data obtained from cells transiently transfected with GFP-Bcl-2 is presented for
comparison. (E) Caspase-3 activation was examined by immunoblotting total cell lysates using an anti-caspase-3 antibody, with a
te c
ance
3short (top) and long (bottom) exposure as shown. Arrows indica
are representative of at least 3 experiments. Statistical signific
not cause caspase-3 cleavage in control cells. Also, the
stable expression of GFP-Bcl-2 reduced the cleavage of
caspase-3 normally observed in cells in which apoptosis had
been induced with staurosporine (Fig. 3E). These data indi-
cate that stable expression of Bcl-2 protected cells from
apoptosis.
u
t
I
eleaved caspase-3. -actin was used as a loading control. Blots
is denoted by (*p < 0.05) and (***p < 0.001).
.6. Higher levels of Bcl-2 expression are achieved
pon transient transfection, compared to stable
ransfection
t is established that the concentration of a heterologously
xpressed protein is generally higher following transient
250 C.J. Hanson et al.
Figure 4 Transiently transfected GFP-Bcl-2 expresses at a higher level than stably transfected GFP-Bcl-2, and its magnitude of
expression correlates with apoptosis. HEK-293 cells were stably or transiently (16 h) transfected with expression vectors for GFP
or GFP-Bcl-2. (A) Expression levels were compared by immunoblotting of total cell lysates, normalised for protein content, with
(Ai) anti-GFP or (Aii) anti-Bcl-2 antibodies (see arrows). -actin was used as a loading control. Blots are representative of at least
3 experiments. (B) The band intensity from immunoblots was normalised to the mean intensity of the transient populations. (C)
Fluorescence of cell populations, analysed using FACS, was normalised to the mean fluorescence of the transient populations. (D
and E) HEK-293 cells were harvested 16 h post-transfection with GFP-Bcl-2. The proportion of cells with sub-G1 DNA content was
determined by FACS analysis of PI stained cells. (Di) Representative density plot of GFP fluorescence. R1 indicates gated cells. (Dii)
Corresponding frequency histogram of cells with sub-G1 DNA in the gated R1 region. (Ei) Same density plot as in Ai, but with the
population of GFP-positive cells segmented into smaller regions (labelled 2—13). (Eii) Analysis of sub-G1 DNA content in the cells
within the regions indicated in Ei. The data are representative of 3 independent experiments. Data represent the mean± S.E.M. of
at least 3 individual experiments, with statistical significance denoted by (*p < 0.05).
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transfection than with stable transfection. We therefore
examined whether GFP-Bcl-2 was indeed expressed at higher
levels following transient transfection of HEK-293 cells,
compared to their stably over-expressing counterparts,
and whether higher levels of expression correlated with
pro-apoptotic behaviour. From immunoblots of total cell
lysates normalised for protein content, it was evident that
with stable transfection Bcl-2 was expressed at a signif-
icantly lower level than following transient transfection
(Fig. 4A and B). Since the stable GFP-Bcl-2-expressing cell
lines cells were continually grown in selection medium,
the entire population was positive for GFP-Bcl-2. In con-
trast, since Lipofectamine 2000 is not 100% effective,
a proportion of the cells that had undergone transient
transfection did not express GFP-Bcl-2 (Figs. 1 and 4).
Considering that some of the Lipofectamine-treated cells
would not have been transfected, the differences between
stable and transient GFP-Bcl-2 cells would have been
even greater than that shown in Fig. 4A and B. Sim-
ilar differences in GFP-Bcl-2 expression were observed
using FACS analysis of GFP fluorescence. This approach
allows selection of GFP positive cells (and thus only
GFP-Bcl-2-expressing cells), and measures absolute fluo-
rescence levels per individual cell, giving a more reliable
representation. The results corroborated those obtained
using immunoblotting, showing that the mean fluores-
cence was significantly lower in cells stably over-expressing
GFP-Bcl-2 compared to populations of transiently trans-
fected cells (Fig. 4C). These data confirm that higher
levels of GFP-Bcl-2 are achieved upon transient over-
expression.
To determine whether there was a direct correlation
between the expression level of GFP-Bcl-2 and apoptosis, a
combined analysis of sub-G1 DNA and GFP-Bcl-2 fluorescence
intensity was undertaken using FACS. Taking a whole popu-
lation of transiently transfected cells indicated that 29% of
the cells had sub-G1 DNA (Fig. 4D). However, if the same
population of cells was analysed on the basis of increas-
ing GFP-Bcl-2 expression, then it became obvious that the
proportion of cells with sub-G1 DNA was augmented in a
supra-linear manner (Fig. 4E). It therefore appears that
higher expression levels of Bcl-2 make its pro-apoptotic
behaviour more prominent.
3.7. Manipulation of Bcl-2 expression levels using
the TREx system
The data presented above suggest that high levels of Bcl-2
expression, generated by transient transfection, are pro-
apoptotic. Whereas, the lower levels of Bcl-2 expression
obtained during selection of cells stably expressing Bcl-2
cells are anti-apoptotic. In order to rule out differences
due to expression paradigm (transient versus stable), a sys-
tem was used where expression levels could be manipulated
using the same cell line and same method of transfec-
tion. To this end, the Tetracycline Regulated Expression
(T-REx) inducible system was used. T-REx-293 cells sta-
bly over-express a tetracycline repressor which allows for
repression and de-repression of a modified CMV promoter
containing Tet operator (TO) sequences. This allows expres-
sion of genes contained within a pcDNA4/TO backbone
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o be precisely regulated [19]. For this purpose, Bcl-2
DNA from pB4-Bcl-2 was sub-cloned into the pcDNA4/TO-
FP expression vector yielding pcDNA4/TO-GFP-Bcl-2, which
s an inducible form of GFP-Bcl-2, termed TO-GFP-Bcl-2.
o over-express GFP-Bcl-2 in TREx-293 cells, transfection
f the TO-GFP-Bcl-2 vector and induction with doxycy-
line (1g/ml; 16 h) are required (note that the protein
xpressed by the TO-GFP-Bcl-2 vector is GFP-Bcl-2; the term
TO-GFP-Bcl-2’ simply relates to its regulation by doxycy-
line).
The essential benefit of the T-REx system for this
tudy is that upon transient transfection and induction
with doxycycline), high levels of GFP-Bcl-2 expression are
chieved. In contrast, upon transfection without induc-
ion expression is constitutively repressed, and a very
ow basal level of GFP-Bcl-2 transcription occurs. To con-
rm doxycycline-dependent expression of TO-GFP-Bcl-2,
otal cell lysates were immunoblotted with anti-Bcl-2
nd anti-GFP antibodies (Fig. 5A). TO-GFP-Bcl-2 migrated
t the expected molecular weight, and was sensitive
o doxycycline induction. Without application of doxy-
ycline, TO-GFP-Bcl-2 transfection evoked a much lesser
xpression of GFP-Bcl-2 (Fig. 5A). Comparison of band
ntensity confirmed that there was a significantly lower
evel of expression in cells where expression had not
een induced with doxycycline (Fig. 5B). To corroborate
hese data, flow cytometry was used to compare GFP
uorescence levels. A significantly lower level of GFP flu-
rescence was recorded in TO-GFP-Bcl-2-transfected cells
n the absence of doxycyline, compared to cells where
xpression had been induced (Fig. 5C). The T-Rex sys-
em therefore provided a suitable system to modulate the
xpression of Bcl-2, whilst using the same transfection
ethod.
.8. Localisation and expression of transiently
ver-expressed TO-GFP-Bcl-2
onfocal microscopy was used to examine the sub-cellular
ocalisation of TO-GFP-Bcl-2 in TREx-293 cells. The fluores-
ent dye ER-Tracker Blue-White DPX was used to highlight
he ER, and TMRE was used to illustrate mitochondria.
ig. 5D and E depict the localisation of TO-GFP-Bcl-2 in cells
ithout induction (panel D; no doxycycline; low level of GFP-
cl-2) or with induction (panel E; 1g/ml doxycycline for
6 h; high levels of GFP-Bcl-2). It is evident that TO-GFP-
cl-2 was correctly localised to both ER and mitochondrial
embranes in the induced and non-induced cells. However,
here was a significant difference in the appearance of the
ells in which TO-GFP-Bcl-2 had been induced. Using the
ame settings for confocal image capture, it was evident
hat the induced cells had greater GFP-Bcl-2 expression and
hat the protein was concentrated into dense perinuclear
ggregates. Furthermore, the specific organelles markers
ndicated that these structures were disrupted. These obser-
ations are presented in a quantitative manner in Fig. 5F.
t is evident that cells transfected with TO-GFP-Bcl-2 and
nduced with doxycycline had similar levels of organelle
isruption as cells transiently transfected with the GFP-
cl-2 used earlier in this study (i.e. in Figs. 1—4). Cells in
hich GFP-Bcl-2 was stably expressed, or following transient
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Figure 5 Higher levels of TO-GFP-Bcl-2 expression in TREx-293 cells are achieved upon doxycycline induction, and can disrupt
organelle structure. TREx-293 cells were treated with or without doxycycline (1g/ml; 16 h), as shown, and were harvested 16 h
post-transfection. (A) Expression of TO-GFP-Bcl-2 was confirmed by immunoblotting of total cell lysates, normalised for protein
content, with anti-Bcl-2 and anti-GFP antibodies (see arrows). -actin was used as a loading control. Blots are representative of
at least 3 experiments. (B) The band intensity from immunoblots was normalised to the mean intensity of induced populations. (C)
Fluorescence of cell populations, analysed using FACS, was normalised to the mean fluorescence of induced populations. Data is
represented as the mean± S.E.M. of at least 3 individual experiments. (D—F) TREx-293 cells treated with or without doxycycline
(1g/ml; 16 h), were imaged 16 h post-transfection. (D and E) Representative confocal images of cells. (Di) TO-GFP-Bcl-2 expression
was not induced, the cells therefore show normal organelle structure. (Ei) TO-GFP-Bcl-2 expression was induced, and the cells have
disrupted organelle structure. (Dii and Eii) Cells were loaded with ER-Tracker Blue-White DPX to illustrate ER structure and (Diii, Eiii)
TMRE to highlight mitochondrial structure. (Div and Eiv) Transmitted light DIC image. (Dv and Ev) GFP/ER-Tracker/TMRE overlay. (Dvi
and Evi) GFP/ER-Tracker/TMRE/DIC overlay. Scale bar = 10m. (F) Using confocal microscopy, fields of view were scored for cells
w S.E.M
p tran
f and
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oith disrupted organelle structure. Data represent the mean±
er day, on 3 individual days. The corresponding data from cells
or comparison. Statistical significance is denoted by (*p < 0.05)
ransfection with TO-GFP-Bcl-2 in the absence of doxycy-
line, still showed some organelle disruption, but it was
ignificantly less common (Fig. 5F). Furthermore, empiri-
al observation of the cells suggested that the extent of
rganelle disruption was milder.
3
a
W
2. of at least 30 fields per coverslip, using at least 3 coverslips
siently and stably transfected with GFP-Bcl-2 data is presented
(***p < 0.001)..9. Induction of TO-GFP-Bcl-2 expression induces
poptosis
e next determined whether the level of TO-GFP-Bcl-
expression influenced cell survival, independent of
ti-ap
w
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transfection paradigm. Cells transiently transfected with
TO-GFP-Bcl-2, but where expression had not been induced
by doxycycline, showed low levels of spontaneous death
(sub-G1 DNA content; 2± 0.7%), similar to that observed in
control cells. Whereas, those cells transiently transfected
with TO-GFP-Bcl-2 in which expression had been induced
showed a significantly higher proportion of cells with sub-
G1 DNA content (18± 2%) (Fig. 6A). The proportion of cell
death following transient transfection with TO-GFP-Bcl-2
Figure 6 High level of TO-GFP-Bcl-2 expression, due to induc-
tion with doxycyline, causes apoptosis and sensitises cells to
apoptotic stimuli. TREx-293 cells were treated with doxycycline
(1g/ml; 16 h) or staurosporine (4M; 4 h) as shown. Cells were
harvested 16 h post-transfection. (A) The proportion of cells
with sub-G1 DNA content was determined by FACS analysis of PI
stained cells. Sub-G1 data is represented as the mean± S.E.M.
of at least 3 individual experiments. Statistical significance is
denoted by (*p < 0.05) and (**p < 0.01). (B) Caspase-3 activation
was examined by immunoblotting of total cell lysates with an
anti-caspase-3 antibody, with a short (top) and long (bottom)
exposure shown, arrows indicate cleaved caspase-3. -actin was
used as a loading control. Blots are representative of at least 3
experiments.
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ith induction was similar to that observed in cells tran-
iently transfected with GFP-Bcl-2 (Fig. 2B). Incubation
ith staurosporine (4M; 4 h) significantly increased the
raction of cells that were apoptotic in all cases, but pro-
uced a dramatic elevation of cell death in cells where
O-GFP-Bcl-2 expression had been induced by doxycycline
Fig. 6A). A similar effect was observed when monitoring
leavage of caspase 3 as a marker of apoptosis induction.
ctive (cleaved) caspase-3 was not detectable in cells where
O-GFP-Bcl-2 expression had not been induced, but follow-
ng doxycycline incubation cleaved caspase-3 was evident
Fig. 6B). These data support the results shown earlier
nd suggest that higher levels of Bcl-2 expression promote
reater induction of apoptosis, even when using the same
xpression paradigm.
Cells stably expressing GFP-Bcl-2 and those transiently
ransfected with TO-GFP-Bcl-2 (without induction) had
imilar amounts of Bcl-2. However, unlike stable Bcl-2
xpression, the low level of TO-GFP-Bcl-2 obtained without
nduction did not protect against apoptosis. As described
bove, TO-GFP-Bcl-2 did not cause spontaneous apopto-
is without doxycycline induction, but it did not prevent
taurosporine-induced apoptosis either (Fig. 6A). It appears
hat the same concentration of Bcl-2 is more efficacious in
nhibiting cell death if it has been constitutively expressed
n a cell, rather than transiently introduced.
.10. Bcl-2 disrupts organelle structure and
nduces apoptosis in a Ca2+-dependent manner
he severe fragmentation of cellular organelles and induc-
ion of apoptosis by Bcl-2 is surprising given the well-known
ro-survival role of this protein. We sought to probe the
echanisms by which high levels of Bcl-2 can deleteriously
ffect cell ultrastructure. Our initial experiments examined
he potential role of Ca2+ in this process, since it has been
reviously shown that acutely elevated cytosolic Ca2+ con-
entrations cause organelle disruption [23—25]. To visualise
rganelles, HEK-293 cells were co-transfected with EGFP
nd DsRed targeted to the ER and mitochondria, respec-
ively. The cells were then incubated with 10M ionomycin
or 2 h and visualised using confocal microscopy. Similar to
he effect of transient Bcl-2 expression, the treatment with
onomycin caused disruption to the ER and mitochondrial
tructure (Fig. 7A).
To determine whether Ca2+ was playing a role in the
cl-2-induced organelle disruption and cell death observed
n this study, two approaches were adopted. The first was
o reduce InsP3-evoked Ca2+ release, and the second was
o buffer cytosolic calcium. The Ca2+-mobilising action of
nsP3 can be prevented by expressing the inositol 1,4,5-
risphosphate 5′-phosphatase enzyme (InsP3 5′Pase), which
ephosphorylates InsP3 to inositol 1,4-bisphosphate (InsP2).
nsP3Rs are not activated by InsP2, and we have observed
hat agonist-mediated Ca2+ release is completely abrogated
y introduction of InsP3 5′pase (unpublished observations).
EK-293 cells were transiently transfected with GFP-Bcl-2
nd InsP3 5′Pase and examined using confocal microscopy. As
epicted in Fig. 7B, the presence of the InsP3 5′Pase signifi-
antly lowered the proportion of GFP-Bcl-2-expressing cells
xhibiting abnormal organelle structure, compared to those
254 C.J. Hanson et al.
Figure 7 Ca2+-dependent apoptosis caused by ionomycin or Bcl-2 provokes organelle fragmentation. (A) Representative confocal
images of HEK-293 cells treated with ionomycin (10M; 2 h). (Ai) Cells were transfected with GFP-ER to illustrate ER structure and
(Aii) DsRed-Mito to highlight mitochondrial structure. (Aiii) A transmitted light DIC image was taken simultaneously. (iv) GFP/DsRed
overlay. (v) GFP/DsRed/DIC co-localisation overlay. The cells were imaged 24 h post-transfection. Scale bar = 10m. (Bi and Ci)
HEK-293 cells were imaged or harvested 16 h post-transfection with the constructs denoted by the columns (note that the InsP3 5′
phosphatase is denoted as InsP35P). Using confocal microscopy, fields of viewwere scored for cells with disrupted organelle structure.
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data represent the mean± S.E.M. of at least 30 fields per cover
roportion of cells with sub-G1 DNA content was determined by
ean± S.E.M. of at least 3 individual experiments. Statistical s
ver-expressing GFP-Bcl-2 alone. In addition to decreasing
′rganelle fragmentation, introduction of the InsP3 5 Pase
educed the extent of apoptosis induced by transient trans-
ection of Bcl-2 (Fig. 7Bii). It therefore appears that both
he organelle disruption and cell death induced by Bcl-2 are
ependent on InsP3R activation.
r
f
t
c
firom 3 coverslips per day on 3 individual days. (Bii and Cii) The
S analysis of PI stained cells. Sub-G1 data is represented as the
cance is denoted by (*p < 0.05) and (**p < 0.01).
To directly test whether elevated cytosolic Ca2+ was
equired for the deleterious actions of transiently trans-
ected Bcl-2, calbindin, a mobile cytosolic Ca2+ buffer, was
ransiently introduced into cells along with GFP-Bcl-2. The
albindin protein was tagged with RFP to enable identi-
cation of co-transfected cells. 16 h post-co-transfection
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Figure 8 Lipid peroxidation occurs during ionomycin- and Bcl-2-induced apoptosis. (A and B) HEK-293 cells were
treated± ionomycin (10M; 2 h) and immunostained. (A and B) Representative confocal images of (A) control (untreated) cells
and (B) cells treated with ionomycin. (Ai and Bi) Cells were probed with an anti-malondialdehyde antibody and (Aii and Bii)
incubated with the nuclear stain, DAPI. (Aiii and Biii) A transmitted light DIC image was taken simultaneously. (Aiv and Biv)
Anti-malondialdehyde/DAPI overlay. (Av and Bv) Anti-malondialdehyde/DAPI/DIC overlay. (C) Representative images of cells tran-
siently transfected with GFP-Bcl-2 for 16 h. (Ci) GFP-Bcl-2 fluorescence. (Cii) Cells were probed with an anti-malondialdehyde
antibody and (Ciii) labelled with the nuclear stain, DAPI. (Civ) A transmitted light DIC image was taken simultaneously. (Cv)
GFP/anti-malondialdehyde/DAPI overlay. (Cvi) GFP/anti-malondialdehyde/DAPI/DIC overlay. Scale bar = 10m.
2 C.J. Hanson et al.
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Figure 9 ROS scavenging prevents Bcl-2-induced organelle
fragmentation. HEK-293 cells were transiently transfected with
GFP-Bcl-2 for 16 h in the continual presence of Trolox. The pro-
portion of cells with normal organelle structure was determined
using confocal microscopy of the GFP fluorescence. The data
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ith GFP-Bcl-2 and RFP-calbindin, cell structure was exam-
ned using confocal microscopy. The presence of calbindin
ignificantly decreased the proportion of cells with frag-
ented organelles, compared to those cells transiently
ver-expressing GFP-Bcl-2 alone (Fig. 7B). However, cal-
indin did not affect the induction of cell death following
ransient transfection of Bcl-2 (Fig. 7Bii).
.11. Transient expression of Bcl-2 causes lipid
eroxidation
he data described above suggest that Ca2+ released from
he ER plays a role in the adverse effects of transiently
xpressed Bcl-2. It is known that high levels of Ca2+ can
ffect mitochondrial function leading to generation of reac-
ive oxygen species (ROS), which can then feedback to the
R promoting further Ca2+ release [7,26]. Our previous work
xamining ionomycin-induced ER fragmentation has shown
hat the organelle disruption was dependent on ROS pro-
uction [25]. To determine whether ROS were contributing
o the destructive effects of transiently expressed Bcl-2,
e examined whether lipid peroxidation, a membrane-
amaging process caused by high levels of ROS, was
ccurring. Malondialdehyde (MDA) is an end-product of
ipid peroxidation, and is readily detectable using spe-
ific antibodies [27]. As we have already observed that
onomycin can lead to generation of ROS, we used this
timulus as a positive control from the MDA assay. Cells
ere incubated with or without 10M ionomycin for 2 h,
nd subsequently immunostained using an anti-MDA anti-
ody. As depicted in Fig. 8A, control cells (not treated
ith ionomycin) showed no sign of MDA immunoreactivity.
n contrast, cells treated with ionomycin showed positive
taining for MDA, indicating that ROS generation leading
o lipid peroxidation had occurred (Fig. 8B). To determine
hether transient expression of Bcl-2 also induced lipid per-
xidation, cells were immunostained and examined using
onfocal microscopy, 16 h post-transfection with GFP-Bcl-
. The images in Fig. 8C indicate that cells expressing
FP-Bcl-2 had disrupted organelle structure and exhibited
ositive staining for MDA. Quantification of the propor-
ion of Bcl-2-transfected cells with disrupted organelle
tructure and MDA immunostaining revealed that the two
ffects were observed together in greater than 50% of cells
n > 100 cells), suggesting that ROS may have contributed
o the adverse effects observed when Bcl-2 was transiently
xpressed. To examine whether ROS was instrumental in
nducing organelle fragmentation downstream of Bcl-2 intro-
uction, the cells were incubated with the ROS scavenger,
rolox, during transient transfection period. As depicted in
ig. 9, Trolox gave a concentration-dependent protection
f organelle structure from the deleterious action of tran-
iently expressed Bcl-2.
. Discussionhe results presented above show that transient trans-
ection of the cDNA encoding Bcl-2 leads to a high level
f protein expression. In this situation, Bcl-2 does not
xhibit its classical anti-apoptotic function. Rather, it
isrupts organelle structure (Fig. 1), sensitises cells to
e
e
o
B
wepresent mean± S.E.M. of 3 individual experiments, with mul-
iple cells per field of view in each experiment.
poptotic stimuli (Fig. 2) and induces spontaneous apop-
osis (Figs. 2 and 3). In contrast, stably transfected Bcl-2
s expressed at lower levels (Fig. 3) and functions in its
stablished anti-apoptotic manner (Fig. 3). Although Bcl-
is targeted to the correct organelles in both expression
aradigms, the differing amounts of protein produced have
rofound, but inverse, consequences on cellular integrity.
The work described in this study was undertaken to
evelop a reliable cell model to explore the biology of Bcl-
. As described earlier, several groups have demonstrated
hat regulation of Ca2+ fluxes by Bcl-2 underlies its anti-
poptotic effect [8,14,28]. However, the actual effect of
cl-2 on cellular Ca2+ signalling is controversial, with dif-
erent laboratories proposing that the protein modulates
arious aspects of Ca2+ homeostasis or release. Our aim,
herefore, was to develop a system in which Bcl-2 expression
ould be modulated, and the protein was correctly targeted
nd functioning. Our studies were carried out using HEK-293
ells, which is a reliable cell type for Ca2+ signalling, since
hey have robust and well-characterised responses to sev-
ral Ca2+-mobilising agonists. Furthermore, they have a low
ndogenous expression of Bcl-2 (Fig. 1).
Since transient transfection of Bcl-2 has been used by
everal groups before, it was surprising to us that is had
uch a drastic effect on cells. There are several advantages
f transient transfection, including rapid protein expression
ithout the need for growth in selective medium. Although
t is known that transient transfection yields populations of
ells with variable degrees of protein expression, it is not
enerally appreciated that this method also gives rise to
igher average levels of Bcl-2.
Our confocal imaging observations suggest that the dele-
erious effects of Bcl-2 were not caused by mistargetting
f the protein. Indeed, the GFP-tagged protein localised
xplicitly with the ER and mitochondria (Fig. 1; see also ref-
rence [4]). Rather, it appeared that high concentrations
f Bcl-2 caused the apparent changes in cellular integrity.
cl-2 is classically considered an anti-apoptotic protein, yet
hen expressed at a high level it caused apoptosis. The
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most direct data, showing that the negative consequences
of Bcl-2 correlate with the extent of expression, and are
independent of transfection paradigm, was obtained using
TO-GFP-Bcl-2. By introducing a doxycycline-inducible vec-
tor, we could demonstrate that the dosage of Bcl-2 was key
to its pro-apoptotic activity (Fig. 5). The same organelle
fragmentation and apoptosis induction was also observed
using transient transfection of Bcl-2 without a GFP tag (data
not shown). Furthermore, expression of GFP by itself did not
cause any deleterious effects. The cell death caused by Bcl-2
expression was determined to be apoptotic since caspase-3
cleavage and DNA fragmentation were evident (Fig. 2). In
addition, the caspase-3 inhibitor zVAD-FMK reduced the cell
death evoked by Bcl-2 expression to close to control lev-
els. Our data concur with previous studies that employed
transient transfection of Bcl-2 and found increased levels of
spontaneous apoptosis [4,29].
In our hands, stable expression of Bcl-2 provides a more
suitable model for exploring Bcl-2 function. Transient and
stable Bcl-2-expressing cells were initially transfected in the
same manner. Thereafter, the transiently transfected cells
were used ∼16 h post-transfection, whilst the stable cells
were allowed to grow in the presence of G418. It is likely
that during the selection of stable Bcl-2-expressing trans-
fectants, those cells with high levels of protein expression
were eliminated by spontaneous apoptosis. The remaining
population of cells had lower Bcl-2 expression and were pro-
tected from apoptosis. Moreover, the differences observed
in the anti-apoptotic effects of low (i.e. low levels of BCl-
2 expression achieved by transient or stable expression in
TO-GFP-Bcl-2 expressing cells exhibited reduced organelle
fragmentation compared to cells transiently expressing GFP-
Bcl-2, but they were not as resistant to apoptotic stimuli as
cells stably expressing GFP-Bcl-2) is suggestive that stable
expression of Bcl-2 enhances the activity of other pro-
survival pathways.
The precise mechanisms underlying the ability of high
levels of Bcl-2 to cause organelle fragmentation and pro-
mote apoptosis are presently unclear. Our data suggest that
excessive levels of Bcl-2 cause organelle fragmentation and
cell death in a Ca2+- and ROS-dependent manner (Figs. 7—9).
Exactly how Bcl-2 leads to accumulation of Ca2+ and ROS is
not known. It is established that Bcl-2 can be cleaved into
a pro-apoptotic moiety by caspase-3, but mutation of the
relevant amino acid (Asp 34) does not protect the cells from
apoptosis [4]. It is possible that Bcl-2 may undergo addi-
tional forms of NH2- or COOH-terminal processing when it
is expressed at high levels [30]. Indeed, in our experiments
with the greatest Bcl-2 expression levels, anti-Bcl-2 anti-
bodies detected multiple bands in the immunoblots (e.g.
Fig. 5A), consistent with proteolytic cleavage of the pro-
tein or accumulation of harmful truncated peptides. Further
work is required to explore how and when Bcl-2 develops
a pro-apoptotic configuration. However, it is interesting to
note that cells possess an endogenous mechanism that limits
the expression of Bcl-2. The 5′ and 3′ untranslated regions of
human Bcl-2 mRNA contain sequences that negatively regu-
late transcription of Bcl-2 [31]. Expression of a Bcl-2 cDNA
clones expressing the 5′ and 3′ untranslated regions reduces
the cell death associated with Bcl-2 expression [30].
In summary, we see marked differences in the biologi-
cal effect of Bcl-2 depending on its expression level. Other
[optotic effect 257
roups have also found concentration-dependent inverse
ffects of Bcl-2, for example on the activity of transcrip-
ion factors [32]. These observations indicate that selection
f the appropriate expression paradigm is crucial when try-
ng to understand the biological role of Bcl-2. High levels of
cl-2 cause apoptosis and severe organelle fragmentation.
ither stable transfection or employing a regulated pro-
oter appear to be the most appropriate methods to study
cl-2 without inducing its pro-apoptotic action. In addition
o its well-known role in promoting cell survival, Bcl-2 has
profound capacity to induce cell death via increases in
ellular Ca2+ and ROS.
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